Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a time scale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wildtype animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.

Reversible photocontrol of dopaminergic transmission in wild-type animals / C. Matera, P. Calvé, V. Casadó-Anguera, R. Sortino, A.M.J. Gomila, E. Moreno, T. Gener, C. Delgado, P. Nebot, D. Costazza, S. Conde-Berriozabal, M. Masana, J. Hernando, V. Casadó, M. Victoria Puig, P. Gorostiza. - (2022 May 17). [10.26434/chemrxiv-2022-8jlxp]

Reversible photocontrol of dopaminergic transmission in wild-type animals

Carlo Matera;
2022-05-17

Abstract

Understanding the dopaminergic system is a priority in neurobiology and neuropharmacology. Dopamine receptors are involved in the modulation of fundamental physiological functions and dysregulation of dopaminergic transmission is associated with major neurological disorders. However, the available tools to dissect the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic manipulation. Here we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control of dopaminergic transmission. We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner. Moreover, it enables reversibly photocontrolling zebrafish motility on a time scale of seconds and allows separating the retinal component of dopaminergic neurotransmission. Azodopa increases the overall neural activity in the cortex of anesthetized mice and displays illumination-dependent activity in individual cells. Azodopa is the first photoswitchable dopamine agonist with demonstrated efficacy in wildtype animals and opens the way to remotely controlling dopaminergic neurotransmission for fundamental and therapeutic purposes.
photochromism; photoswitch; azobenzene; dopamine; G protein-coupled receptor; GPCR; brainwave; in vivo electrophysiology; photopharmacology; optopharmacology; azologization; caged compound; optogenetics
Settore CHIM/08 - Chimica Farmaceutica
Settore BIO/14 - Farmacologia
Settore CHIM/06 - Chimica Organica
https://chemrxiv.org/engage/chemrxiv/article-details/6278180987d01f9bddddd1d4
File in questo prodotto:
File Dimensione Formato  
azodopa_maintext.pdf

accesso aperto

Descrizione: main text
Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 5.29 MB
Formato Adobe PDF
5.29 MB Adobe PDF Visualizza/Apri
azodopa_suppinfo.pdf

accesso aperto

Descrizione: supplementary information
Tipologia: Altro
Dimensione 6.81 MB
Formato Adobe PDF
6.81 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/928288
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact